Back to

Dr Mark Donoghoe

Senior Research Fellow

B Sc (Adv) (Hons), PhD

Medicine & Health

Faculty Office

Phone

+61-2-9065 6602

E-mail

m.donoghoe@unsw.edu.au

Location

Wallace Wurth Building (C27), Level 5 Kensington UNSW Sydney NSW 2052

Journal articles | 2025

Foster C; Donoghoe MW; Battisti A; D'Eugenio F; Harborne K; Venville T; Lagos CDP; Mendel JT; Bagge R; Barsanti S; Bellstedt S; Boecker A; Chen Q; Derkenne C; Ferré-Matteu A; Gjergo E; Gupta A; Muller EGM; Santucci G; Park HJ; Remus RS; Thater S; Van De Sande J; Vaughan S; Brough S; Croom SM; Valenzuela LM; Wisnioski E, 2025, 'The MAGPI Survey: The kinematic morphology-density relation (or lack thereof) and the Hubble sequence at z ∼0.3', Publications of the Astronomical Society of Australia, http://dx.doi.org/10.1017/pasa.2025.19

Journal articles | 2025

Ha L; Wakefield CE; Jacovou J; Johnston K; Drew D; Donoghoe MW; Mizrahi D; Lourenco RDA; Cohn RJ; Taylor N; Signorelli C; Roughley K; Joyner C; Wright A, 2025, '‘Making Moves’: Protocol for a hybrid effectiveness-implementation pre-post trial of a co-designed online physical activity program for childhood cancer survivors', JSAMS Plus, 5, http://dx.doi.org/10.1016/j.jsampl.2025.100099

Journal articles | 2025

Schilstra CE; Wakefield CE; McLoone J; Wiener L; Donoghoe MW; Hoffman RI; Echodu M; Ortiz R; Ilbawi A; Cayrol J, 2025, 'Development of a World Health Organization international survey assessing the lived experience of people affected by cancer: outcomes from pilot testing, user feedback, and survey revision', Supportive Care in Cancer, 33, http://dx.doi.org/10.1007/s00520-025-09372-2

Journal articles | 2025

Signorelli C; Mcloone J; Wakefield C; Donoghoe M; Alchin JE; Johnston K; Baldwin R; Thornton-Benko E; Webber K; Foreman T; Neville K; Cohn R, 2025, 'Engage: A Survivorship Program to Improve Childhood Cancer Survivors' Self-Efficacy and Quality of Life', JCO Oncology Practice, http://dx.doi.org/10.1200/OP-24-00815

Journal articles | 2024

Cayrol J; Wakefield CE; Ilbawi A; Donoghoe M; Hoffman R; Echodu M; Schilstra C; Ortiz R; Wiener L; Gok C, 2024, 'The lived experience of people affected by cancer: A global cross-sectional survey protocol', PLoS ONE, 19, pp. e0294492, http://dx.doi.org/10.1371/journal.pone.0294492

Journal articles | 2024

Donoghoe MW; Marschner IC, 2024, 'Parameter expansion for fitting regression models with non-negativity constraints', Communications in Statistics: Simulation and Computation, 53, pp. 4412 - 4429, http://dx.doi.org/10.1080/03610918.2022.2154791

Journal articles | 2024

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2024, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, http://dx.doi.org/10.1111/add.16730

Journal articles | 2024

Hetherington K; Wakefield CE; McGill BC; Tucker KM; Donoghoe MW; Daly R; Hunter JD; Ballinger M; Fuentes-Bolanos NA; Ziegler DS, 2024, 'When genetics and pediatric cancer collide: Understanding and optimizing families' experiences', Neuro-Oncology Advances, 6, http://dx.doi.org/10.1093/noajnl/vdae133

Journal articles | 2024

Robertson EG; Hetherington K; Daly R; Donoghoe MW; Handelsman N; Ziegler DS; Wakefield CE, 2024, 'The feasibility and acceptability of collecting psychosocial outcome measures embedded within a precision medicine trial for childhood cancer', Cancer Medicine, 13, http://dx.doi.org/10.1002/cam4.7339

Journal articles | 2023

Body A; Donoghoe MW; Ahern ES; Lal L; Downie P; Leahy MF; Fuentes-Bolanos N; Anazodo A; Padhye B; Hamad N; Wakefield CE; Segelov E, 2023, 'Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer', ANNALS OF ONCOLOGY, 34, pp. S1104 - S1104, http://dx.doi.org/10.1016/j.annonc.2023.09.888

Journal articles | 2023

Craig AT; Leong RNF; Donoghoe MW; Muscatello D; Mojica VJC; Octavo CJM, 2023, 'Comparison of statistical methods for the early detection of disease outbreaks in small population settings', IJID Regions, 8, pp. 157 - 163, http://dx.doi.org/10.1016/j.ijregi.2023.08.007

Journal articles | 2023

Gereis JM; Hetherington K; Robertson EG; Daly R; Donoghoe MW; Ziegler DS; Marshall GM; Lau LMS; Marron JM; Wakefield CE, 2023, 'Parents’ and adolescents’ perspectives and understanding of information about childhood cancer precision medicine', Cancer, 129, pp. 3645 - 3655, http://dx.doi.org/10.1002/cncr.34914

Journal articles | 2023

McGill BC; Wakefield CE; Tucker KM; Daly RA; Donoghoe MW; Vetsch J; Warby M; Fuentes-Bolanos NA; Barlow-Stewart K; Kirk J; Courtney E; O’Brien TA; Marshall GM; Pinese M; Cowley MJ; Tyrrell V; Deyell RJ; Ziegler DS; Hetherington K, 2023, 'Parents’ expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial', Cancer, 129, pp. 3620 - 3632, http://dx.doi.org/10.1002/cncr.34917

Journal articles | 2023

Nagabushan S; Hamayun M; Fardell JE; Donoghoe M; Bland E; Bye A; Jacobson E; Manoharan N; Ziegler DS; McLoone JK; Johnson AM; Cohn RJ, 2023, 'LGG-11. COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE ‘BENIGN TUMOR’ PERCEPTION', Neuro-Oncology, 25, pp. i57 - i58, http://dx.doi.org/10.1093/neuonc/noad073.221

Journal articles | 2023

Ong KL; O'Connell RL; Januszewski AS; Donoghoe MW; Gebski V; Sullivan D; Rye KA; Scott RS; Best JD; Taskinen M-R; Simes RJ; Jenkins A; Keech AC, 2023, 'Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study', DIABETES, 72, http://dx.doi.org/10.2337/db23-1350-P

Journal articles | 2023

Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL, 2023, 'Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome', Clinical Endocrinology, 98, pp. 567 - 577, http://dx.doi.org/10.1111/cen.14851

Journal articles | 2023

Shamsa A; Gilchrist RB; Robertson DM; Rodgers RJ; Donoghoe MW; Ledger WL; Abbott JA; Riepsamen AH, 2023, 'Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis', Reproductive Sciences, 30, pp. 1521 - 1527, http://dx.doi.org/10.1007/s43032-022-01107-6

Journal articles | 2023

Spitzer H; Berry S; Donoghoe M; Pelkmans L; Theis FJ, 2023, 'Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps', Nature Methods, 20, pp. 1058 - 1069, http://dx.doi.org/10.1038/s41592-023-01894-z

Journal articles | 2023

Wakefield CE; Hetherington K; Robertson EG; Donoghoe MW; Hunter JD; Vetsch J; Marron JM; Tucker KM; Marshall GM; Broom A; Haber M; Tyrrell V; Malkin D; Lau L; Mateos MK; O’Brien TA; Ziegler DS, 2023, 'Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives', British Journal of Cancer, 129, pp. 1634 - 1644, http://dx.doi.org/10.1038/s41416-023-02429-1

Journal articles | 2022

Hetherington K; Wakefield CE; Kunalan KPK; Donoghoe MW; McGill BC; Fardell JE; Daly R; Deyell RJ; Ziegler DS, 2022, 'Quality of Life (QoL) of Children and Adolescents Participating in a Precision Medicine Trial for High-Risk Childhood Cancer', Cancers, 14, http://dx.doi.org/10.3390/cancers14215310

Journal articles | 2022

RIEPSAMEN AH; DONOGHOE MW; INDRAN IR; LIEN S; HECHTMAN L; ROBERTSON DM; GILCHRIST RB; YONG E-L; LEDGER WL, 2022, 'Serum GDF9 and BMP15 as Markers of Ovarian Function in Healthy Women and Women with Polycystic Ovary Syndrome', Fertility & Reproduction, 04, pp. 141 - 141, http://dx.doi.org/10.1142/s266131822274053x

Journal articles | 2022

Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RDA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN; Gok C, 2022, 'Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia', BMC Cancer, 22, pp. 985, http://dx.doi.org/10.1186/s12885-022-10072-x

Journal articles | 2021

Hsu J; Sansom-Daly UM; Hetherington K; Ellis SJ; Donoghoe MW; Cohn RJ; Zentella-Tusie A; Wakefield CE, 2021, 'Health service and medication use of parents of childhood cancer survivors: a controlled comparison study', Acta Oncologica, 60, pp. 1325 - 1334, http://dx.doi.org/10.1080/0284186X.2021.1955968

Journal articles | 2021

Kamaladasa DS; Sansom-Daly UM; Hetherington K; McGill BC; Ellis SJ; Kelada L; Donoghoe MW; Evans H; Anazodo A; Patterson P; Cohn RJ; Wakefield CE, 2021, 'How Are Families Faring? Perceived Family Functioning among Adolescent and Young Adult Cancer Survivors in Comparison to Their Peers', Journal of Adolescent and Young Adult Oncology, 10, pp. 711 - 719, http://dx.doi.org/10.1089/jayao.2020.0215

Journal articles | 2021

Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Exploratory analysis of serum concentrations of oocyte biomarkers growth differentiation factor 9 and bone morphogenetic protein 15 in ovulatory women across the menstrual cycle', Fertility and Sterility, 116, pp. 546 - 557, http://dx.doi.org/10.1016/j.fertnstert.2021.02.001

Journal articles | 2021

Riepsamen AH; Donoghoe MW; Baerwald A; Pankhurst MW; Lien S; Chong YH; Robertson DM; Ledger WL; Gilchrist RB, 2021, 'Serum Concentrations of GDF9 and BMP15 Across the Menstrual Cycle', Journal of the Endocrine Society, 5, pp. A734 - A735, http://dx.doi.org/10.1210/jendso/bvab048.1494

Journal articles | 2021

Sansom‐daly UM; Wakefield CE; Ellis SJ; McGill BC; Donoghoe MW; Butow P; Bryant RA; Sawyer SM; Patterson P; Anazodo A; Plaster M; Thompson K; Holland L; Osborn M; Maguire F; O’dwyer C; Lourenco RDA; Cohn RJ; Sansom-Daly U, 2021, 'Online, group‐based psychological support for adolescent and young adult cancer survivors: Results from the recapture life randomized trial', Cancers, 13, pp. 2460, http://dx.doi.org/10.3390/cancers13102460

Journal articles | 2021

Sansom‐daly UM; Wakefield CE; Signorelli C; Donoghoe MW; Anazodo A; Sawyer SM; Osborn M; Viney R; Daniell N; Faasse K; Cohn RJ; Sansom-Daly U, 2021, 'Patterns and predictors of healthcare use among adolescent and young adult cancer survivors versus a community comparison group', Cancers, 13, pp. 5270, http://dx.doi.org/10.3390/cancers13215270

Journal articles | 2021

Wakefield CE; Sansom‐daly UM; McGill BC; Hetherington K; Ellis SJ; Robertson EG; Donoghoe MW; McCarthy M; Kelada L; Girgis A; King M; Grootenhuis M; Anazodo A; Patterson P; Lowe C; Dalla‐pozza L; Miles G; Cohn RJ; Sansom-Daly U, 2021, 'Providing psychological support to parents of childhood cancer survivors: ‘cascade’ intervention trial results and lessons for the future', Cancers, 13, pp. 5597, http://dx.doi.org/10.3390/cancers13225597

Journal articles | 2020

Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Samra JS; Harris M; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Donoghoe M; Goldstone S; Yip S; Pavlakis N; Aghmesheh M; Joubert W; Grimes D; Harris M; Bagia S; Jaber M; Gananadha S; Bryant R; Nathanson L; Cavallucci D; Fawcett J; O’Rourke T; Croagh D; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2

Journal articles | 2020

Barlow EL; Lambie N; Donoghoe MW; Naing Z; Hacker NF, 2020, 'The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva', Journal of Oncology, 2020, http://dx.doi.org/10.1155/2020/3739075

Journal articles | 2019

Kelada L; Wakefield CE; Heathcote LC; Jaaniste T; Signorelli C; Fardell JE; Donoghoe M; McCarthy MC; Gabriel M; Cohn RJ, 2019, 'Perceived cancer-related pain and fatigue, information needs, and fear of cancer recurrence among adult survivors of childhood cancer', Patient Education and Counseling, 102, pp. 2270 - 2278, http://dx.doi.org/10.1016/j.pec.2019.06.022

Journal articles | 2019

Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB, 2019, 'Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 during IVF and in Women with Reproductive Pathologies', Endocrinology, 160, pp. 2298 - 2313, http://dx.doi.org/10.1210/en.2019-00264

Journal articles | 2019

Robertson EG; Wakefield CE; Cohn RJ; Battisti RA; Donoghoe MW; Ziegler DS; Fardell JE; Mitchell R; O'Brien TA, 2019, 'Piloting a parent and patient decision aid to support clinical trial decision making in childhood cancer', Psycho-Oncology, 28, pp. 1520 - 1529, http://dx.doi.org/10.1002/pon.5109

Journal articles | 2019

Stenson BJ; Donoghoe M; Brocklehurst P; Davis PG; Juszczak E; Marschner IC; Simes J; Tarnow-Mordi WO, 2019, 'Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen Trials', Journal of Pediatrics, 204, pp. 301 - 304.e2, http://dx.doi.org/10.1016/j.jpeds.2018.08.033

Journal articles | 2018

Craig AT; Joshua CA; Sio AR; Donoghoe M; Betz-Stablein B; Bainivalu N; Dalipanda T; Kaldor J; Rosewell AE; Schierhout G, 2018, 'Epidemic surveillance in a low resource setting: Lessons from an evaluation of the Solomon Islands syndromic surveillance system, 2017', BMC Public Health, 18, pp. 1395, http://dx.doi.org/10.1186/s12889-018-6295-7

Journal articles | 2018

Donoghoe MW; Marschner IC, 2018, 'Logbin: An R package for relative risk regression using the log-binomial model', Journal of Statistical Software, 86, http://dx.doi.org/10.18637/jss.v086.i09

Journal articles | 2017

Donoghoe MW; Gebski V, 2017, 'The importance of censoring in competing risks analysis of the subdistribution hazard', BMC Medical Research Methodology, 17, pp. 52, http://dx.doi.org/10.1186/s12874-017-0327-3

Journal articles | 2017

Mitchell P; Siva S; Kok PS; O'Byrne K; Yeung A; Livingstone A; Donoghoe M; Yip S; Stockler MR, 2017, 'NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.', Journal of Clinical Oncology, 35, pp. TPS9097 - TPS9097, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps9097

Journal articles | 2017

Nowak A; Kok P-S; Livingstone A; Lesterhuis WJ; Yip S; Donoghoe M; Lam W-S; Stockler M, 2017, 'P2.06-025 DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In', Journal of Thoracic Oncology, 12, pp. S1086 - S1087, http://dx.doi.org/10.1016/j.jtho.2016.11.1518

Journal articles | 2016

Barbour A; O'Rourke N; Chan H; Chua YJ; Kench J; Hicks RJ; Samra JS; Pavlakis N; Haghighi KS; Yip S; Donoghoe M; Friend C; Burge ME; Fawcett J; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2016, 'Initial survival outcomes for the AGITG GAP study - a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.4105

Journal articles | 2016

Donoghoe MW; Marschner IC, 2016, 'Estimation of adjusted rate differences using additive negative binomial regression', Statistics in Medicine, 35, pp. 3166 - 3178, http://dx.doi.org/10.1002/sim.6960

Journal articles | 2016

Tarnow-Mordi W; Stenson B; Kirby A; Juszczak E; Donoghoe M; Deshpande S; Morley C; King A; Doyle LW; Fleck BW; Davis PG; Halliday HL; Hague W; Cairns P; Darlow BA; Fielder AR; Gebski V; Marlow N; Simmer K; Tin W; Ghadge A; Williams C; Keech A; Wardle SP; Kecskes Z; Kluckow M; Gole G; Evans N; Malcolm G; Luig M; Wright I; Stack J; Tan K; Pritchard M; Gray PH; Morris S; Headley B; Dargaville P; Simes RJ; Brocklehurst P, 2016, 'Outcomes of two trials of oxygen-saturation targets in preterm infants', New England Journal of Medicine, 374, pp. 749 - 760, http://dx.doi.org/10.1056/NEJMoa1514212

Journal articles | 2016

Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC, 2016, 'Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Metabolism: Clinical and Experimental, 65, pp. 783 - 793, http://dx.doi.org/10.1016/j.metabol.2015.12.008

Journal articles | 2015

Donoghoe MW; Marschner IC, 2015, 'Flexible regression models for rate differences, risk differences and relative risks', International Journal of Biostatistics, 11, pp. 91 - 108, http://dx.doi.org/10.1515/ijb-2014-0044

Journal articles | 2014

Darlow BA; Marschner SL; Donoghoe M; Battin MR; Broadbent RS; Elder MJ; Hewson MP; Meyer MP; Ghadge A; Graham P; McNeill NJ; Kuschel CA; Tarnow-Mordi WO, 2014, 'Randomized controlled trial of oxygen saturation targets in very preterm infants: Two year outcomes', Journal of Pediatrics, 165, http://dx.doi.org/10.1016/j.jpeds.2014.01.017

Journal articles | 2014

Donoghoe MW; Marschner IC, 2014, 'Stable computational methods for additive binomial models with application to adjusted risk differences', Computational Statistics and Data Analysis, 80, pp. 184 - 196, http://dx.doi.org/10.1016/j.csda.2014.06.019

Journal articles | 2013

Blinman P; Gainford C; Donoghoe M; Martyn J; Blomfield P; Grant P; Kichenadasse G; Vaughan M; Brand A; Shannon C; Gebski V; Stockler M; Friedlander M, 2013, 'Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: An ANZGOG study', Journal of Gynecologic Oncology, 24, pp. 359 - 366, http://dx.doi.org/10.3802/jgo.2013.24.4.359

Journal articles | 2013

Chan KH; O’Connell RL; Sullivan DR; Hoffmann LS; Rajamani K; Whiting M; Donoghoe MW; Vanhala M; Hamer A; Yu B; Stocker R; Ng MKC; Keech AC, 2013, 'Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study', Diabetologia, 56, pp. 724 - 736, http://dx.doi.org/10.1007/s00125-012-2818-4

Journal articles | 2013

Stenson BJ; Tarnow-Mordi WO; Darlow BA; Simes J; Juszczak E; Askie L; Battin M; Bowler U; Broadbent R; Cairns P; Davis PG; Deshpande S; Donoghoe M; Doyle L; Fleck BW; Ghadge A; Hague W; Halliday HL; Hewson M; King A; Kirby A; Marlow N; Meyer M; Morley C; Simmer K; Tin W; Wardle SP; Brocklehurst P, 2013, 'Oxygen saturation and outcomes in preterm infants', New England Journal of Medicine, 368, pp. 2094 - 2104, http://dx.doi.org/10.1056/NEJMoa1302298

Journal articles | 2012

Stanton K; Rao S; Assimes T; Wang B; McGee S; Harada R; Wilson A; Narasimhan B; Donoghoe M; Olin J; Cooke J; Ng M, 2012, 'Asymmetric Dimethylarginine (ADMA) Levels Correlate with Peripheral Vascular Disease Severity but not Coronary Artery Disease', Heart, Lung and Circulation, 21, pp. S11 - S11, http://dx.doi.org/10.1016/j.hlc.2012.05.034

Journal articles | 2012

Ting R; Keech A; Drury P; Donoghoe M; Hedley J; Jenkins AJ; Davis T; Lehto S; Celermajer DS; Simes J; Kushwin R; Stanton K; Suranyi MG, 2012, 'Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment', Diabetes Care, 35, pp. 218 - 225, http://dx.doi.org/10.2337/dc11-1109

Journal articles | 2011

Davis TME; Ting R; Best JD; Donoghoe MW; Drury PL; Sullivan DR; Jenkins AJ; O'Connell RL; Whiting MJ; Glasziou PP; Simes RJ; Kesäniemi YA; Gebski VJ; Scott RS; Keech AC, 2011, 'Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study', Diabetologia, 54, pp. 280 - 290, http://dx.doi.org/10.1007/s00125-010-1951-1

Journal articles | 2011

Donoghoe MW; Gebski V, 2011, 'Impact of the censoring distribution on time-to-event problems in the presence of competing risks', Trials, 12, http://dx.doi.org/10.1186/1745-6215-12-s1-a140

Journal articles | 2011

Joly F; Ray-Coquard I; Fabbro M; Donoghoe M; Boman K; Sugimoto A; Vaughan M; Reinthaller A; Vergote I; Ferrandina G; Dell'Anna T; Huober J; Pujade-Lauraine E, 2011, 'Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial', Gynecologic Oncology, 122, pp. 226 - 232, http://dx.doi.org/10.1016/j.ygyno.2011.04.019

Journal articles | 2011

Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TME; Colman PG; Manning P; Fulcher G; Keech AC, 2011, 'Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial', Cardiovascular Diabetology, 10, http://dx.doi.org/10.1186/1475-2840-10-102

Journal articles | 2011

Sullivan D; Forder P; Simes J; Whiting M; Kritharides L; Merrifield A; Donoghoe M; Colman PG; Graham N; Haapamäki H; Keech A, 2011, 'Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study', Diabetes Research and Clinical Practice, 94, pp. 284 - 290, http://dx.doi.org/10.1016/j.diabres.2011.07.028

Journal articles | 2011

Ting R; Davis T; Drury P; Donoghoe M; Rajamani K; Best J; Kesaniemi Y; Keech A, 2011, 'Cardiovascular Risk, Renal Status and Fenofibrate Safety in the FIELD Study', Heart, Lung and Circulation, 20, pp. S202 - S202, http://dx.doi.org/10.1016/j.hlc.2011.05.497

Journal articles | 2010

Rajamani K; Donoghoe M; Li L; Ting R-D; Colman P; Scott R; Laakso M; Keech A, 2010, 'FENOFIBRATE REDUCES PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES: THE FENOFIBRATE INTERVENTION AND EVENT LOWERING IN DIABETES (FIELD) STUDY', ATHEROSCLEROSIS SUPPLEMENTS, 11, pp. 219 - 220, http://dx.doi.org/10.1016/S1567-5688(10)71046-1

Journal articles | 2010

Ting R-D; Davis TME; Drury PL; Donoghoe M; Rajamani K; Best JD; Kesaniemi YA; Keech AC, 2010, 'MS544 CARDIOVASCULAR AND RENAL SAFETY OF FENOFIBRATE IN THE FIELD STUDY', Atherosclerosis Supplements, 11, pp. 219 - 219, http://dx.doi.org/10.1016/s1567-5688(10)71044-8

Journal articles | 2009

Sullivan D; Donoghoe M; Simes J; George J; Keech T, 2009, 'Abstract: P496 LONG-TERM FENOFIBRATE USE IS ASSOCIATED WITH REDUCED PREVALENCE OF LIVER ENZYME ELEVATION IN THE FIELD STUDY', Atherosclerosis Supplements, 10, pp. e809 - e809, http://dx.doi.org/10.1016/s1567-5688(09)70791-3
Preprints | 2024

Body A; Donoghoe M; Lal L; Wakefield C; Ahern ES; Anazodo A; Fuentes Bolanos NA; Padhye B; Downie P; Opat S; Hamad N; Leahy MF; Milch V; Segelov E, 2024, Vaccine beliefs, adverse effects, and quality of life in patients with cancer undergoing routine COVID-19 vaccination, http://dx.doi.org/10.1101/2024.06.02.24308345

Conference Papers | 2024

McLoone J; Signorelli C; Wakefield C; Donoghoe M; Thornton-Benko E; Johnston K; Baldwin R; Cohn R, 2024, ''Engage': A novel distance-delivered intervention to support childhood cancer survivorship care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 76 - 77

Conference Papers | 2023

Cohen J; Gohil P; Lovell A; Winkler L; Donoghoe M; Mellett K; Wakefield C, 2023, 'EFFECT OF AN ONLINE NUTRITION INTERVENTION (REBOOT-KIDS) ON THE DIETARY INTAKE OF YOUNG CHILDHOOD CANCER SURVIVOR'S FRUIT AND VEGETABLE INTAKE: A RANDOMISED-CONTROLLED TRIAL', in PEDIATRIC BLOOD & CANCER, WILEY, pp. S531 - S531

Conference Abstracts | 2023

Nagabushan S; Hamayun M; Fardell JE; Donoghoe M; Bland E; Bye A; Jacobson E; Manoharan N; Ziegler DS; McLoone JK; Johnson AM; Cohn RJ, 2023, 'COGNITIVE, ACADEMIC, AND QUALITY OF LIFE OUTCOMES IN SURVIVORS OF PEDIATRIC LOW-GRADE GLIOMA: CHALLENGING THE 'BENIGN TUMOR' PERCEPTION.', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, DC, Washington, Vol. 25, presented at 7th Pediatric Neuro-Oncology Research Conference, DC, Washington, 22 June 2023 - 24 June 2023, http://dx.doi.org/10.1093/neuonc/noad073.221

Conference Abstracts | 2022

Body A; Wakefield C; Luong VTT; Donoghoe M; Fuentes Bolanos NA; Anazodo A; Ho C; Grech L; Ahern ES; Segelov E, 2022, 'Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. LBA12068 - LBA12068, http://dx.doi.org/10.1200/jco.2022.40.17_suppl.lba12068

Conference Papers | 2022

Body A; Wakefield C; Vi TTL; Donoghoe M; Bolanos NAF; Anazodo A; Ho C; Grech L; Ahern ES; Segelov E, 2022, 'Patient-reported toxicity and quality of life following Sars-CoV-2 vaccination in adults and children with cancer', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 03 June 2022 - 07 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000891791500044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts | 2022

McLoone J; Signorelli C; Wakefield CE; Donoghoe M; Johnston K; Bell R; Cohn RJ, 2022, 'The 'ENGAGE' program: Effective childhood cancer survivorship care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 80 - 80

Preprints | 2022

Spitzer H; Berry S; Donoghoe M; Pelkmans L; Theis F, 2022, Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps, http://dx.doi.org/10.1101/2022.05.07.490900

Conference Abstracts | 2019

Robertson E; Wakefield C; Cohn R; Robert B; Donoghoe M; Ziegler D; Fardell J; Mitchell R; O'Brien T, 2019, 'Delta: A Parent and Patient Decision Aid to Support Clinical Trial Decision-Making in Childhood Cancer', in PEDIATRIC BLOOD & CANCER, WILEY, Vol. 66, pp. S118 - S118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488458001090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2017

Mitchell P; Siva S; Kok PS; O'Byrne K; Yeung A; Livingstone A; Donoghoe M; Yip S; Stockier MR, 2017, 'NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy in advanced non-small cell lung cancer, progressing after first or second line chemotherapy.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 02 June 2017 - 07 June 2017, http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.9097

Conference Posters | 2017

Nowak A; Kok P-S; Livingstone A; Lesterhuis WJ; Yip S; Donoghoe M; Lam W-S; Stockler M, 2017, 'DREAM - A Phase 2 Trial of DuRvalumab with First Line chEmotherApy in Mesothelioma with a Safety Run In', Vol. 12, pp. S1086 - S1087, http://dx.doi.org/10.1016/j.jtho.2016.11.1518

Conference Abstracts | 2015

Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J; Donoghoe M; Walker K; Burge ME; Gananadha S; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115

Conference Papers | 2012

Stanton KM; Rao SD; Assimes T; Wang B-Y; McGee S; Harada RK; Wilson A; Narasimhan B; Donoghoe M; Brown C; Keech A; Olin JW; Cooke JP; Ng MK, 2012, 'Plasma Asymmetric Dimethylarginine Levels Correlate with Peripheral Arterial Disease Severity but not Coronary Artery Disease', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208885006387&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2011

Jenkins AJ; Whiting M; Sullivan D; Best JD; Barter P; Donoghoe M; Januszewski AS; Karschimkus CS; Blankenberg S; Simes J; Scott R; Laakso M; Taskinen M-R; Keech AC, 2011, 'Inflammation and Oxidative Stress in Type 2 Diabetes Vascular Complications: Predictive Power and Effects of Fenofibrate in the Fenofibrate Intervention and Event Lowering in Diabetes Study', in DIABETES, AMER DIABETES ASSOC, pp. A9 - A9

Conference Papers | 2011

Keech AC; Rajamani JK; Best JD; Hankey G; Donoghoe MW; Li L; Jenkins AJ; Ting R; Davis TME; Phillips P; Barter P, 2011, 'Predictors of peripheral neuropathy and effects of fenofibrate among 9,795 subjects with type 2 diabetes: the fenofibrate intervention and event lowering in diabetes (FIELD) study', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, pp. S81 - S82, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2011

Ting R; Davis TME; Jenkins AJ; Drury PL; Donoghoe MW; Rajamani JK; Kesaniemi AY; Best JD; Keech AC, 2011, 'Association of renal status and cardiovascular risk, and safety of fenofibrate in renal impairment in the FIELD study of 9,795 subjects with type 2 diabetes', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, pp. S24 - S24, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 12 September 2011 - 16 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307671300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2011

Ting R; Donoghoe M; Jenkins AJ; Hedley J; Rajamani K; Drury PL; Davis TME; Celermajer D; Simes RJ; Keech AC, 2011, 'Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment - the FIELD study', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 323 - 324, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208702703033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2010

Keech AC; Alicia J; Whiting M; Barter P; Sullivan DR; Donoghoe M; Januszewski A; Karschimkus C; Blankenberg S; Simes J; Scott R; Laakso M; Taskinen M-R; Best JD, 2010, 'Novel Cardiovascular Risk Factor Prediction of Cardiovascular Events in the (Type 2 Diabetes) FIELD Study and Effects of Fenofibrate', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208231602961&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2010

Rajamani K; Donoghoe M; Li L; Ting R-D; Colman PG; Drury P; Laakso M; Keech AC, 2010, 'Fenofibrate Reduces Peripheral Neuropathy in Type 2 Diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS

Conference Papers | 2009

Keech A; Drury P; Davis TM; Donoghoe M; Laakso M; Whiting M; Scott R; D'Emden MC, 2009, 'Protection Against Nephropathy With Fenofibrate in Type 2 Diabetes Mellitus: The FIELD Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FL, Orlando, pp. S419 - S420, presented at 82nd Scientific Session of the American-Heart-Association, FL, Orlando, 14 November 2009 - 18 November 2009

Conference Papers | 2009

Sullivan D; Donoghoe M; Simes J; George J; Keech T, 2009, 'LONG-TERM FENOFIBRATE USE IS ASSOCIATED WITH REDUCED PREVALENCE OF LIVER ENZYME ELEVATION IN THE FIELD STUDY', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207957101492&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Papers | 2009

Ting R-D; Donoghoe M; Li L-P; Davis TM; O'Connell R; Gebski V; Best JD; Kesaniemi A; Laakso M; Keech AC, 2009, 'Risk Predictors of First Microvascular Complications in Type 2 Diabetes Mellitus: The FIELD Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FL, Orlando, pp. S496 - S496, presented at 82nd Scientific Session of the American-Heart-Association, FL, Orlando, 14 November 2009 - 18 November 2009

2022: President's Award for Leadership in Statistics, Statistical Society of Australia (Awarded to the 2020-2022 Branch Councils)
2014: Award for Excellence in Postgraduate Research, Statistical Society of Australia
2014: Certificate of Merit, Statistical Society of Australia (Outstanding presentation by a young statistician in the EJG Pitman Prize)
2008: Norbert Quirk Prize IV, University of Sydney (Best essay in a mathematical subject)

Follow

Dr Mark Donoghoe

Follow me